Cite

    Toshifumi Hibi et al.. “Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.” Medicine, vol. 95, no. 24, 2016, pp. e3863–. http://access.bl.uk/ark:/81055/vdc_100052094287.0x000035